Certain individuals cannot tolerate 'conventional' doses of radiation thera
py. This is known to be true of patients with ataxia-telangiectasia and lig
ase IV deficiency. Although in vitro testing may not correlate completely w
ith clinical radiosensitivity, fibroblasts and lymphoblasts from patients,v
ith both of these disorders have been clearly shown to be radiosensitive. U
sing a colony survival assay (CSA) to test lymphoblastoid cells after irrad
iation with 1 Gy, a variety of other genetic disorders have been identified
as strong candidates for clinical radiosensitivity. such as Nijmegen break
age syndrome, Mrel 1 deficiency, and Fanconi's anemia. These data are prese
nted and considered as a starting-point for the inherited basis of human ra
diosensitivity.